Fenbendazole is a benzimidazole-class veterinary anthelmintic used in animal-health products for the control of susceptible gastrointestinal parasites. It is an established veterinary pharmaceutical active ingredient and is used in formulations intended for various animal species, subject to applicable veterinary regulations and approved product labelling.
Fenbendazole is valued for its broad-spectrum anthelmintic activity and its suitability for incorporation into veterinary formulations. Its quality depends on chemical identity, assay, related substances, moisture and compliance with the applicable pharmacopoeial requirements.
Fenbendazole is used as an active ingredient in veterinary pharmaceutical formulations for the control of susceptible parasitic worms. It is used in animal-health preparations for relevant livestock and companion-animal applications, in accordance with the approved formulation, species indication and local regulatory requirements.
The API is suitable for consideration in veterinary formulation development and manufacturing where the required quality, regulatory and documentation criteria are met.
Fenbendazole acts by binding to parasite β-tubulin and interfering with microtubule formation. This disrupts essential cellular processes, including nutrient uptake and intracellular transport, contributing to the elimination of susceptible parasites.
Fenbendazole is typically described as a white or almost white powder. It is practically insoluble in water and has limited solubility in common solvents. The physical and chemical characteristics should be verified against the current pharmacopoeial monograph and approved batch specification.
Fenbendazole is covered by Ph. Eur. monograph 1208. The referenced pharmacopoeial requirements include:
The assay is performed by potentiometric titration, while related substances are evaluated by liquid chromatography. These are different tests and should not be described as a single HPLC assay.
The current official pharmacopoeial edition and the approved product specification should be checked before publishing release limits or claiming compliance.
Fenbendazole should be packed in suitable, well-closed containers that protect the material from contamination and environmental exposure. Store according to the applicable product specification, protected from light and under the approved storage conditions.
Handle Fenbendazole in accordance with the current Safety Data Sheet (SDS) and site procedures. Avoid unnecessary dust generation and inhalation. Use appropriate protective gloves, eye protection and respiratory protection based on the workplace risk assessment. Follow applicable environmental and waste-disposal requirements.
1. What is Fenbendazole?
Fenbendazole is a benzimidazole-class veterinary anthelmintic active ingredient.
2. What is the CAS number of Fenbendazole?
The CAS number is 43210-67-9.
3. What is the molecular formula of Fenbendazole?
Its molecular formula is C₁₅H₁₃N₃O₂S.
4. What is the molecular weight of Fenbendazole?
Its molecular weight is approximately 299.35 g/mol.
5. Which pharmacopoeial monograph covers Fenbendazole?
Fenbendazole is covered by Ph. Eur. monograph 1208.
6. What is the pharmacopoeial assay range?
The referenced Ph. Eur. requirement is 98.0%–101.0% on the dried-substance basis.
7. What documents should buyers request?
Buyers should request the current batch COA, SDS, product specification and applicable quality or regulatory documentation.
For product enquiries, technical specifications, quality documentation, packaging and supply information, contact the sales team through the official website enquiry channel. Please specify the required pharmacopoeial standard, grade and intended veterinary application.
| Parameter | Specification |
|---|---|
| Appearance | White or almost white crystalline powder |
| Identification | IR and HPLC complaint |
| Assay (HPLC) | 98.0%–101.0% |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.3% |
| Heavy Metals | NMT 10 ppm |
| Solubility | Slightly soluble in water |